CSE Bulletin: Reinstatement - HAVN Life Sciences Inc. (HAVN)
Short Interest in HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Decreases By 40.0%
CSE Bulletin: Suspension - HAVN Life Sciences Inc. (HAVN)
Short Interest in HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Increases By 170.8%
HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Sees Significant Decrease in Short Interest
HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Short Interest Down 84.1% in November
HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Short Interest Update
HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Short Interest Up 272.0% in October
HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Sees Large Increase in Short Interest
Short Interest in HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Grows By 56.3%
HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Short Interest Up 42.7% in July
CSE Bulletin: Consolidation - HAVN Life Sciences Inc. (HAVN)
HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details
HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022
Mycotopia Therapies, Inc. Expands Presence In The Registered Mushroom Sector With HAVN Life Sciences Inc.
HAVN Life Session at Psychedelic Capital: Jan 2022 by Microdose
HAVN Life Successfully Exports Naturally Derived Psilocybin From Its Jamaica Facility Into Canada
Mycotopia Therapies Issues CEO Letter to Stockholders, Reports on Significant Progress and Outlook for 2021
Press Release: HAVN Life Announces Departure of Rick Brar as Director
No Data